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AbstrACt
Introduction The Emergency Management of Severe 
Burns (EMSB) referral criteria have been implemented 
for optimal triaging of burn patients. Admission to a burn 
centre is indicated for patients with severe burns or with 
specific characteristics like older age or comorbidities. 
Patients not meeting these criteria can also be treated 
in a hospital without burn centre. Limited information is 
available about the organisation of care and referral of 
these patients. The aims of this study are to determine 
the burn injury characteristics, treatment (costs), quality 
of life and scar quality of burn patients admitted to a 
hospital without dedicated burn centre. These data will 
subsequently be compared with data from patients 
with<10% total bodysurface area (TBSA) burned who 
are admitted (or secondarily referred) to a burn centre. If 
admissions were in agreement with the EMSB, referral 
criteria will also be determined.
Methods and analysis In this multicentre, prospective, 
observational study (cohort study), the following two 
groups of patients will be followed: 1) all patients (no age 
limit) admitted with burn-related injuries to a hospital 
without a dedicated burn centre in the Southwest 
Netherlands or Brabant Trauma Region and 2) all 
patients (no age limit) with<10% TBSA burned who are 
primarily admitted (or secondarily referred) to the burn 
centre of Maasstad Hospital. Data on the burn injury 
characteristics (primary outcome), EMSB compliance, 
treatment, treatment costs and outcome will be collected 
from the patients’ medical files. At 3 weeks and at 3, 6 
and 12 months after trauma, patients will be asked to 
complete the quality of life questionnaire (EuroQoL-5D), 
and the patient-reported part of the Patient and Observer 
Scar Assessment Scale (POSAS). At those time visits, 
the coordinating investigator or research assistant will 
complete the observer-reported part of the POSAS.
Ethics and dissemination This study has been exempted 
by the medical research ethics committee Erasmus MC 
(Rotterdam, The Netherlands). Each participant will provide 
written consent to participate and remain encoded during 
the study. The results of the study are planned to be 
published in an international, peer-reviewed journal.
trial registration number NTR6565.
IntroduCtIon 
Burns cause significant morbidity and 
mortality worldwide. Globally, some studies 
are available on the epidemiology of emer-
gency department (ED) treatments of burn 
injuries,1–8 including three from the Neth-
erlands.7–9 These data were limited to home 
and leisure accidents; work-related burn inju-
ries were not included.
Depending on the severity, burn injuries 
may require specialised burn care. In order 
to enable proper triaging and referral, 
strengths and limitations of this study
 ► This study will provide insight into care of burn pa-
tients both in hospitals with and without a dedicated 
burn centre.
 ► It is a prospective, multicentre, observational study 
with a best possible methodological design.
 ► Participation of over 20 hospitals will increase the 
reliability and generalisability of the data.
 ► Although the study will be mostly relevant for the 
Netherlands, it is also informative for other regions.
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the Emergency Management of Severe Burns (EMSB) 
referral criteria have been implemented (box 1).10
In 2014, 322 patients with burns or inhalation injury 
were admitted to a hospital in the trauma region of South-
west Netherlands. Of these patients, 109 (34%) were 
admitted to hospitals without specialised burn centre. 
There is a lack of insight into the epidemiology, treat-
ment (including treatment costs) and outcome (both 
clinical results and quality of life) of the patients treated 
in hospitals without burn centre.
In order to get insight into the epidemiology of burn 
patients, detailed data collection on patient characteris-
tics, aetiology, burn injury characteristics, treatment and 
outcome is critical. Such data are currently not avail-
able from current registries. The Dutch Burn Repos-
itory R3 only registers data for patients admitted to a 
burn centre.11 The National Injury Surveillance System 
(in Dutch: Letsel Informatie Systeem; www. veiligheid. 
nl)12 and the National Medical Registration (in Dutch: 
Landelijke Medische Registratie; www. dutchhospitaldata. 
nl)13 register non-admitted and admitted patients, respec-
tively. Both are insufficient, as they register patients based 
on the main diagnosis, which may not always be the burn 
injury. The Dutch National Trauma Registry (in Dutch: 
Landelijke Trauma Registratie; www. lnaz. nl) registers all 
admitted trauma patients. It encodes burn wounds, but 
with limited detail, and does not contain relevant treat-
ment and outcome data.
Based on the above, there are currently no data available 
that provide sufficient details about patients admitted to 
a hospital without burn centre. It is also not clear if these 
are different for patients with similar burn injury severity 
admitted to a burn centre. The main aim of this study is to 
determine the burn injury characteristics of burn patients 
admitted to a hospital without dedicated burn centre. 
Secondary aims are 1) to determine if these admissions 
were in agreement with the EMSB referral criteria; 2) to 
determine the treatment and direct medical costs, the 
quality of life (EuroQoL-5D (EQ-5D)) and scar quality 
(Patient and Observer Scar Assessment Scale (POSAS)) 
for these patients until 12 months follow-up and 3) 
to compare the injury pattern and outcome of these 
patients with burn patients with <10% total body surface 
area (TBSA) burned who are admitted (or secondarily 
referred) to a burn centre. We expect that burn patient 
admission outside the burn centre is restricted to a 
maximum of 10% TBSA, and that outcome is similar to 
that achieved for a subgroup with similar burn injury 
severity admitted to a burn centre.
MEthods And AnAlysEs
study design and setting
This study will follow a multicentre, prospective, obser-
vational study design (cohort study). Patients will be 
recruited from every hospital in two large trauma 
regions in The Netherlands, the Southwest Netherlands 
trauma region and Network Emergency Care Brabant. 
The Burn Centre of Maasstad Hospital is included in 
the Southwest Netherlands trauma area. The following 
18 hospitals in The Netherlands will participate: Admi-
raal De Ruyter Ziekenhuis (Goes), Albert Schweitzer 
Ziekenhuis (Dordrecht), Amphia Ziekenhuis (Breda), 
Beatrix Ziekenhuis (Gorinchem), Bravis Ziekenhuis 
(Roosendaal), Catharina Ziekenhuis (Eindhoven), Elis-
abeth-TweeSteden Ziekenhuis (Tilburg), Elkerliek Ziek-
enhuis (Helmond), Erasmus MC, University Medical 
Centre (Rotterdam), Franciscus Gasthuis and Vlietland 
(Rotterdam), IJsselland Ziekenhuis (Capelle aan de 
IJssel), Ikazia Ziekenhuis (Rotterdam), Jeroen Bosch 
Ziekenhuis (‘s-Hertogenbosch), Burn Centre Maasstad 
Hospital (Rotterdam), Máxima Medisch Centrum (Veld-
hoven), Van Weel-Bethesda Ziekenhuis (Dirksland) and 
ZorgSaam Zeeuws-Vlaanderen (Terneuzen). The study 
started in September 2017 and the recruiting periods will 
be 18 months. With a follow-up of 1 year, the presentation 
of data will be expected by the end of 2020.
study registration
The study is registered at the Netherlands Trial Register 
(NTR6565; 12 July 2017).
recruitment and informed consent
Eligible persons admitted with burn-related injuries (or 
the parents of paediatric patients) will be informed about 
the study as soon as possible after hospital presentation. 
They may receive the information at the ED or while 
admitted at the surgical ward. The local staff will ask 
permission to send contact details to the research team. 
On receipt of that permission, a local contact person 
in the participating hospital will provide details of the 
patient to the research team. The coordinating investi-
gator or research assistant will contact the patient (or 
parents) to explain the study, and will send the informa-
tion brochure and informed consent form. The coordi-
nating investigator or a research assistant will attend the 
patient’s outpatient visit in the hospital (at approximately 
3 weeks after admission) in order to further explain 
the study, answer any question the patient (or parents) 
box 1 Emergency Management of severe burns referral 
criteria10
1. The percentage total body surface area burned (TBSA 
burned; >10% TBSA in adults or >5% in children).
2. Burns of special areas (face, hands, feet, perineum, genitalia and 
major joints).
3. Full thickness burns >5% TBSA burned.
4. Electrical burns.
5. Chemical burns.
6. Burns with associated inhalation injury.
7. Circumferential burns of limbs or chest.
8. Extremes of age (children and elderly).
9. Pre-existing medical disorders, which could complicate manage-
ment and prolong recovery or effect mortality.
10. Associated trauma.
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may have and for signing informed consent. This gives 
patients on average 2–3 weeks to consider their participa-
tion. As data collection also includes investigation of the 
TBSA and extent of burn wounds, it is not possible to give 
patients more time to consider their participation.
In order to reduce bias as much as possible, the follow-up 
measurements by the clinical investigator or research assis-
tant will be performed using a standardised protocol.
study population and eligibility criteria
The study population will consist of a group of patients 
admitted to a hospital without dedicated burn centre or 
who are admitted to a dedicated burn centre. In order to 
be eligible to participate in this study, a subject must meet 
all of the following criteria:
1. Patients with burn-related injuries (no age limit), ad-
mitted to a hospital without dedicated burn centre 
in the trauma regions of Southwest Netherlands or 
Brabant; or patients with <10% TBSA burned, who are 
primarily admitted or secondarily referred to the burn 
centre of Maasstad Hospital.i
2. Provision of informed consent.
A potential subject who meets any of the following 
criteria will be excluded from participation in this study:
1. Patients who died <24 hours due to severity of non-
burn injuries (eg, severe head injury).
2. Patients with incomplete or unknown contact informa-
tion.
3. Insufficient comprehension of the Dutch or English 
language to understand the questionnaires.
outcome measures
The burn-related injury pattern will serve as primary 
outcome measure. Information on the following items, 
representing injuries and mechanism, will be collected 
from the patients’ medical files:
 ► Inhalation injury (yes or no).
 ► Body regions burned, severity (% TBSA burned as 
assessed by a trained research physician).
 ► Extent of burns (superficial dermal, deep dermal or 
subdermal).
 ► Setting (home, work or other).
 ► Burn aetiology (scald, flame, contact, chemical or 
other).
The secondary outcome measures are:
1. Compliance with EMSB referral criteria (yes or no).
2. Treatment.
3. Healthcare use in hospital with associated treatment 
costs.
4. Health-related quality of life (EuroQol-5D-3L (EQ-5D-
3L)).
5. POSAS.
i Ten per cent has been chosen as we expect that patients 
admitted outside the burn centre will have no more that 10% 
TBSA burned. This is also in line with the EMSB referral 
criteria.10 The % TBSA will be assessed during physical exam-
ination by a research physician who has had elaborate training 
for this at the participating dedicated burn centre.
The following treatment characteristics will be collected:
 ► Prehospital transport (ambulance, helicopter emer-
gency medical services, or other).
 ► Level of trauma care (level 1, 2 or 3).
 ► Required care (ward or intensive care unit).
 ► Resuscitation (amount of fluid <24 hours after 
admission).
 ► Intubation (yes or no).
 ► Bronchoscopy (yes or no).
 ► Wound treatment (wound dressing, topical therapy or 
other).
 ► Date of the first operation.
 ► Escharotomy (yes or no).
 ► Type of operation (split skin grafting, full-thickness 
skin grafting or excision and primary closure).
 ► % TBSA that needed skin grafting.
 ► Expansion of split skin graft (1:1, 1:1.5, 1:3 or 1:6).
 ► Total number of operations.
 ► Indication for second, third and any subsequent 
operation.
 ► Number of outpatient department visits.
 ► Date of discharge from hospital.
 ► Reconstructive surgery (release/excision with split 
skin grafting, full-thickness grafting or laps).
In order to determine the treatment costs, the use 
of hospital resources will be collected from medical 
files directly. All direct medical costs due to treatment, 
complications and events during follow-up (eg, ED visit, 
diagnostic workup, therapy, events, surgery, admissions, 
follow-up visits) will be collected. The economic evalua-
tion will be in accordance with the Dutch guideline and 
will use cost prices where possible.14 Medical costs will be 
calculated by multiplying the volumes of healthcare use 
with the corresponding unit prices.
The EQ-5D is a validated questionnaire for measuring 
health-related quality of life.15 16 Its use is recommended 
for the assessment of quality of life in trauma patients, 
especially for economic assessments.17 18 The EQ-5D-3L 
descriptive system consists of five dimensions of health 
(mobility, self-care, usual activities, pain/discomfort 
anxiety/depression), each with three possible answers. 
Scores are converted to a utility score ranging from zero 
to one, with lower scores indicating poorer quality of 
life. The EQ Visual Analogue Score records the respon-
dents self-rated health status on a vertical (0–100) visual 
analogue scale. Patients aged 16 years or older will be 
asked to complete the EQ-5D themselves. Paediatric 
patients (<16 years) will be asked to compete the youth 
version of the EQ-5D, or their parent(s) will be asked to 
complete a proxy version of the EQ-5D youth version.
The POSAS V.2.0 ( www. posas. org)19 consists of two 
parts: a patient scale and an observer scale, which aim to 
provide a rating of several measured of scar quality (vascu-
larity, pigmentation, relief/texture, thickness, pliability, 
surface area, pain and itching/pruritus). Patients aged 
16 years or older and parents of younger paediatric 
patients will complete the patient-reported part, a trained 
observer will complete the observer-reported part.
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other data collected
The following additional data will be collected in order 
to describe the study population, patient characteris-
tics, additional injury characteristics and burn-related 
(adverse) events:
 ► Patient characteristics: age, gender, American Society 
of Anesthesiologists classification, comorbidities 
(diabetes or other).
 ► Additional injury characteristics: Injury Severity 
Score, Abbreviated Injury Score, for all nine anatom-
ical regions as registered in the trauma registry).
 ► Burn-related (adverse) events: hematoma (yes or no), 
excessive blood loss (requiring blood transfusion), 
wound infection (requiring antibiotic and/or surgical 
treatment) (yes or no), pneumonia (yes or no), graft 
loss requiring surgical intervention (or vac therapy; 
yes or no) or other.
 ► Outcome-related variables: duration of hospital 
admission, time to wound closure (calculated from 
date of admission and date of last wound dressing), 
percentage graft take 5–7 days postburn, discharge 
destination (home, other hospital, burn centre, reha-
bilitation facility or other) and mortality (possibly 
burn-related; yes or no).
study procedures, data collection methods and participant 
timelines
Patients will be followed for 1 year, with visits planned at 
3 weeks (window 2–4 weeks), 3 months (window 11–15 
weeks), 6 months (window 5–7 months) and 12 months 
(window 12–14 months) after admission (table 1). One 
additional, optional visit is planned at 6 weeks (window 
5–7 weeks) in case the burn wound has not closed at 
3 weeks. Wound closure is defined as 95% closure, as 
judged on wound inspection by the research physician 
and the local treating physician or specialised wound care 
nurse. In case of disagreement, consensus will be reached 
by discussion. The coordinating investigator or research 
assistant will be present at each outpatient department 
visit of the enrolled patients for direct collection of data. 
The study will not interfere with treatment or follow-up.
Patient characteristics, injury characteristics and any other 
relevant data will be collected from the patient’s medical files 
as soon as possible after signing informed consent.
Treatment and other clinical data such as adverse events 
will be collected (partly from the patient files) at each 
follow-up visit. During these regular clinical visits, any 
radiographs or digital photos that are routinely obtained 
will be collected. For the purpose of the study, additional 
details concerning treatment and outcome that are not 
mentioned in the patient’s hospital files, may be regis-
tered on the case report forms directly. At the 1-year 
follow-up visit, the coordinating investigator or research 
assistant will document any secondary intervention that 
may be planned for the patient.
As soon as possible after inclusion, patients will be 
asked to complete the EQ-5D-3L reflecting their preinjury 
quality of life. At 3, 6 and at 12 months after the primary 
hospital admission, patients (or the parents of paediatric 
patients) will be asked to complete the EQ-5D-3L and the 
patient-reported part of the POSAS. The coordinating 
Table 1 Schedule of events
Event forms Screening
3 weeks 6 weeks* 3 months 6 months 12 months
(2–4 weeks) (5–7 weeks) (11–15 weeks) (6–7 months) (12–14 months)
Screening X
Informed consent X
Patient characteristics X
Injury characteristics X
Radiology X† X† X† X† X†
Digital photo X† X† X† X† X†
Treatment characteristics X X X X X
Outcome details X X X X X
Adverse events X X X X X
Clinical FU X X X X X
Healthcare consumption X X X X X
EQ-5D X‡ X X X
POSAS X X X
Early withdrawal § § § § §
*Optional visit; will only take place if wounds are not closed at 3 weeks.
†Only if treating surgeon requests these images.
‡Asking for EQ-5D preburn.
§Only at time of withdrawal.
EQ-5D, EuroQoL-5D; FU, follow-up; POSAS, Patient and Observer Scar Assessment Scale.
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investigator or research assistant will complete the physi-
cian-reported part of the POSAS.
blinding
Patients, the research physician who determines % TBSA, 
wound closure and scar quality, and the statistician will 
not be blinded.
sample size
Given the epidemiological nature of the primary aim and 
the lack of information of the population admitted to a 
hospital without burn centre, a formal sample size calcula-
tion was not made. By including all patients treated in the 
trauma regions of Southwest Netherlands and Brabant 
during 18 months, as well as all patients with <10% TBSA 
burned who are primarily admitted or secondarily referred 
to a burn centre, the maximum number of inclusions will 
be achieved in both cohorts. The larger the number of 
patients, the more reliable the analysis will be. Enrolling 
all patients possible will result in the highest reliability of 
data (ie, accurate point estimate with lowest possible vari-
ance). Based on the data in the annual report of Trauma 
Centre Southwest Netherland (ie, 109 patients admitted 
outside the burn centre in the year 2014), we expect to 
include approximately 300 patients in 18 months in the 
two trauma regions combined.
statistical analysis
Data will be analysed using the Statistical Package for the 
Social Sciences (SPSS) V.21.0 or higher (SPSS, Chicago, 
Illinois, USA) and will be reported following the Strength-
ening the Reporting of Observational studies in Epidemi-
ology guidelines. Missing values will not be replaced by 
imputation. Normality of continuous data will be tested 
with the Shapiro-Wilk test, and homogeneity of variances 
will be tested using the Levene’s test. A p value <0.05 will 
be taken as threshold of statistical significance in all statis-
tical tests, and all tests will be two-sided. No interim anal-
ysis is planned.
First, descriptive analysis will be performed in order to 
report the outcome measures and other collected data. 
Data will be reported for the entire population as well as 
separately for the group of patients admitted to a hospital 
without versus with a burn centre. For continuous data 
(eg, EQ-5D and POSAS), the mean and SD (parametric 
data) or the median and quartiles (non-parametric data) 
will be reported. The only exception are cost data, these 
will be reported as mean with 95% CI. The 95% CI around 
the mean costs will be approximated by non-parametric 
bootstrapping. For categorical data (eg, EMSB compli-
ance), the number and frequencies will be reported.
Next univariate analysis will be done in order to compare 
the two cohorts. Statistical significance of difference between 
the two groups will be tested using a Student’s t-test (para-
metric, continuous data; with or without equal variance 
assumed as applicable), Mann-Whitney U test (non-para-
metric, continuous data) or Χ2 test or Fisher’s exact test 
(categorical data, as applicable).
Subgroups will be determined based on the patients 
included. Relevant subgroups can be children versus 
adults versus elderly, subgroups with different percent-
ages TBSA burned or patients admitted in compliance 
versus disagreement with the EMSB referral criteria. 
Should formal testing between the latter two subgroups 
be feasible, this will be done as described above.
The economic evaluation will include costs for health-
care. Direct and indirect, medical and non-medical cost 
will be measured as indicated in the Dutch guidelines 
for economic evaluations, using standard, published cost 
prices where possible.14
data management and monitoring
Data will be encoded and stored in a pass-word protected 
OpenClinica database with restricted access to the 
researchers only. Data will be entered once. Quality of 
the entered data will be monitored by checking entry for 
a random sample of patients prior to database locking.
Patient and public involvement
The need for this study emerged from meetings of the 
Association of Dutch Burn Centres as well as the Dutch 
Burns Foundation, representing both healthcare profes-
sionals and patients. Input into the design, comparison 
and outcome measures was given during presentation 
for the Scientific Board of the Dutch Burns Foundation. 
Patients were not directly involved in the subsequent 
writing of the protocol, nor were they directly involved in 
the recruitment to and conduct of the study. A summary 
of the main results will be made available to study partic-
ipants on request.
Ethics and dissemination
This study will be conducted according to the principles of 
the Declaration of Helsinki (64th World Medical Association 
General Assembly, Fortaleza, Brazil, October 2013).
Approval has been obtained from the local hospital 
boards in all participating centres. Following review of the 
protocol (V.1.0, 22 May 2017), the MREC concluded that 
this study is not subject to the Medical Research Involving 
Human Subjects Act (WMO). They concluded that the 
study is a medical/scientific research, but no patients are 
subjected to procedures or are required to follow rules 
of behaviour. Consequently, the statutory obligation to 
provide insurance for subjects participating in medical 
research (article 7 of the WMO) does not apply. Any 
important changes in the protocol will be submitted to the 
accredited MREC. The results of the study are planned to 
be published in an international, peer-reviewed journal 
and presented at national and international trauma 
and burn care meetings. Each participating centre will 
provide a group author to every publication. No personal 
data of study participants will be presented.
dIsCussIon
Burns cause significant morbidity and mortality world-
wide, and depending on the severity, burn injuries may 
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require specialised burn care in a dedicated burn centre. 
In order to enable optimal triaging and referral to a 
burn centre, the EMSB referral criteria have been imple-
mented.10 Whereas extensive injury and outcome regis-
tration exists for patients admitted to a dedicated burn 
centre, there are currently no data available that provide 
sufficient details about patients admitted to a hospital 
without burn centre. Successful completion of this study 
will provide more insight into the percentage of patients 
admitted to a hospital without dedicated burn centre. It 
will also provide us detailed data on patient and injury 
characteristics, EMSB compliance, treatment, treatment 
costs, relevant outcome data and quality of life of burn 
patients with primary admission at a hospital without 
burn centre as well as patients with <10% TBSA burned 
who are secondarily referred to a burn centre.
Twenty-one hospitals will participate. Although 
the participation of multiple hospitals may intro-
duce treatment bias, it also makes the results more 
generalisable.
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